Condensed Consolidated Statement of Changes in Stockholders’ Equity (Unaudited) - USD ($)	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Total
Balance at Dec. 31, 2017	$ 6,882	$ 18,346,914	$ (923,074)	$ 17,430,722
Balance, shares at Dec. 31, 2017	6,881,794
Stock-based compensation expense for restricted stock awards and stock options		389,215		389,215
Net income/loss			(808,655)	(808,655)
Balance at Mar. 31, 2018	$ 6,882	18,736,129	(1,731,729)	17,011,282
Balance, shares at Mar. 31, 2018	6,881,794
Balance at Dec. 31, 2018	$ 6,869	19,867,259	(4,720,291)	15,153,837
Balance, shares at Dec. 31, 2018	6,868,679
Stock-based compensation expense for restricted stock awards and stock options		452,525		452,525
Issuance of common stock for consulting services	$ 6	34,494		34,500
Issuance of common stockfor consulting services, shares	6,000
Net income/loss			646,615	646,615
Balance at Mar. 31, 2019	$ 6,875	$ 20,354,278	$ (4,073,676)	$ 16,287,477
Balance, shares at Mar. 31, 2019	6,874,679